Gary Birnbaum

1.6k total citations
59 papers, 1.2k citations indexed

About

Gary Birnbaum is a scholar working on Immunology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Gary Birnbaum has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 20 papers in Pathology and Forensic Medicine and 12 papers in Neurology. Recurrent topics in Gary Birnbaum's work include Multiple Sclerosis Research Studies (19 papers), Peripheral Neuropathies and Disorders (9 papers) and T-cell and B-cell Immunology (9 papers). Gary Birnbaum is often cited by papers focused on Multiple Sclerosis Research Studies (19 papers), Peripheral Neuropathies and Disorders (9 papers) and T-cell and B-cell Immunology (9 papers). Gary Birnbaum collaborates with scholars based in United States, Canada and Austria. Gary Birnbaum's co-authors include Linda Kotilinek, Howard L. Weiner, Marc E. Weksler, E. John Orav, Peter Tsairis, Gregory W. Siskind, J. R. Lehrich, Charles N. Luttrell, Peter C. Dau and Jack H. Petajan and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Gary Birnbaum

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Birnbaum United States 22 491 337 306 236 166 59 1.2k
B. Storch–Hagenlocher Germany 19 594 1.2× 488 1.4× 514 1.7× 259 1.1× 176 1.1× 54 1.9k
A. S. D. Spiers United Kingdom 23 296 0.6× 231 0.7× 199 0.7× 238 1.0× 503 3.0× 93 1.9k
Etsuko Yamazaki Japan 19 313 0.6× 123 0.4× 123 0.4× 153 0.6× 257 1.5× 93 1.0k
Stefan M. Weiner Germany 21 274 0.6× 223 0.7× 226 0.7× 145 0.6× 208 1.3× 56 1.4k
Norio Chihara Japan 12 492 1.0× 336 1.0× 388 1.3× 590 2.5× 87 0.5× 46 1.4k
A P Warin United Kingdom 18 135 0.3× 199 0.6× 176 0.6× 146 0.6× 252 1.5× 68 1.3k
Simon Rinaldi United Kingdom 22 202 0.4× 134 0.4× 703 2.3× 292 1.2× 95 0.6× 61 1.6k
Rafael Arroyo Spain 26 762 1.6× 611 1.8× 224 0.7× 356 1.5× 333 2.0× 76 1.7k
Pia Svendsen Denmark 16 115 0.2× 397 1.2× 120 0.4× 263 1.1× 135 0.8× 30 1.1k
J.J. Twomey United States 18 156 0.3× 502 1.5× 72 0.2× 174 0.7× 150 0.9× 32 1.0k

Countries citing papers authored by Gary Birnbaum

Since Specialization
Citations

This map shows the geographic impact of Gary Birnbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Birnbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Birnbaum more than expected).

Fields of papers citing papers by Gary Birnbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Birnbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Birnbaum. The network helps show where Gary Birnbaum may publish in the future.

Co-authorship network of co-authors of Gary Birnbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Birnbaum. A scholar is included among the top collaborators of Gary Birnbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Birnbaum. Gary Birnbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quittner, Alexandra L., et al.. (2024). P391 A national survey to inform feasibility of adding mental health variables to the Cystic Fibrosis Foundation Patient Registry. Journal of Cystic Fibrosis. 23. S188–S188. 1 indexed citations
2.
Birnbaum, Gary, et al.. (2017). High dose biotin as treatment for progressive multiple sclerosis. Multiple Sclerosis and Related Disorders. 18. 141–143. 37 indexed citations
3.
Birnbaum, Gary. (2014). Stopping Disease Modifying Therapy in Progressive Multiple Sclerosis - A Prospective Study (P7.207). Neurology. 82(10_supplement). 2 indexed citations
4.
Birnbaum, Gary. (2013). Multiple sclerosis clinician's guide to diagnosis and treatment. 1 indexed citations
5.
Birnbaum, Gary. (2009). Multiple Sclerosis. 1 indexed citations
6.
Birnbaum, Gary. (2009). Making a Diagnosis of Multiple Sclerosis. PubMed. 98. 35–58. 6 indexed citations
7.
Mirowski, Marek, Anna Janecka, Ewa Balcerczak, et al.. (2004). Uptake of radiolabeled morphiceptin and its analogs by experimental mammary adenocarcinoma: in vitro and in vivo studies. Nuclear Medicine and Biology. 31(4). 451–457. 3 indexed citations
8.
Vyshkina, Tamara, Yin Yao Shugart, Gary Birnbaum, Thomas Leist, & Bernadette Kálmán. (2004). Association of haplotypes in the β-chemokine locus with multiple sclerosis. European Journal of Human Genetics. 13(2). 240–247. 21 indexed citations
9.
Birnbaum, Gary, Linda Kotilinek, Cedric S. Raine, et al.. (1998). Heat shock proteins and experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 90(2). 149–161. 27 indexed citations
10.
Birnbaum, Gary & Linda Kotilinek. (1997). Heat Shock or Stress Proteins and Their Role As Autoantigens in Multiple Sclerosis. Annals of the New York Academy of Sciences. 835(1). 157–167. 22 indexed citations
12.
Birnbaum, Gary, Linda Kotilinek, & Lisa Albrecht. (1993). Spinal fluid lymphocytes from a subgroup of multiple sclerosis patients respond to mycobacterial antigens. Annals of Neurology. 34(1). 18–24. 37 indexed citations
14.
Birnbaum, Gary & Linda Kotilinek. (1990). Immunologic differences in murine glial cells and their association with susceptibility to experimental allergic encephalomyelitis. Journal of Neuroimmunology. 26(2). 119–129. 7 indexed citations
15.
Weiner, Howard L., Peter C. Dau, B. Khatri, et al.. (1989). Double‐blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology. 39(9). 1143–1143. 111 indexed citations
16.
Birnbaum, Gary, et al.. (1986). Disparate responses of lymphocyte clones to cells of monozygotic twins discordant for multiple sclerosis. Journal of Neuroimmunology. 11(3). 237–243. 2 indexed citations
17.
Birnbaum, Gary, et al.. (1981). Human Suppressor Lymphocytes II. Changes in Concanavalin A Inducible Suppressor Cells With Age. Journal of Gerontology. 36(4). 410–415. 2 indexed citations
18.
Birnbaum, Gary. (1980). The pleuropulmonary consequences of esophageal rupture: an experimental model. Annals of Emergency Medicine. 9(6). 337–337. 5 indexed citations
19.
Birnbaum, Gary. (1973). Guillain-Barré Syndrome. Archives of Neurology. 28(4). 215–215. 3 indexed citations
20.
Birnbaum, Gary, et al.. (1969). Cytomegalovirus infections in newborn infants. The Journal of Pediatrics. 75(5). 789–795. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026